Mag-aso, Gracelyn G.

HRN: 24-99-82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2024
METRONIDAZOLE 500MG (TAB)
05/18/2024
05/25/2024
ORAL
500mg/tab
TID
Intestinal Amoebiasis
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: